In practice, this meant that antibiotics were not prescribed even for patients with high serum biomarkers for infection, such as C-reactive protein or procalcitonin, as the specificity of the two was not good enough to predict secondary bacterial pneumonia in COVID-19 patients [14,15,16]. Here, CRP is linked to bacterial pneumonia.